Dynavax Technologies Corporation and GlaxoSmithKline Expand Their...
Oct 21, 2011 | Posted by: roboblogger | Full story: BioSpace
RKELEY, CA, Oct 21, 2011 -- Dynavax Technologies Corporation announced today the expansion of its worldwide strategic alliance with GlaxoSmithKline focused on toll-like receptor inhibitors.
Melton Mowbray, UK
#1 Oct 26, 2011
the ecdysone (insect estrogen) receptor, a ligand-activated transcription factor found in the nuclei of insect cells. This in turn leads to the activation of many other genes and can cause many deseases such as TB!
Add your comments below
|More Than 300 Operators Now Using PeerApp Ultra... (Mar '13)||Mar '13||Tony||1|
|Infortrend's Flagship ZFS-Based Nas Offers 8 GB... (Dec '12)||Dec '12||Ernest Berkoh||1|
|Chick-Fil-A'd: Bully Fired After Video Goes Viral (Aug '12)||Aug '12||TheBlackSheep||1|
|Abitibi Royalties Inc./Malartic CHL Joint Ventu... (Feb '12)||Feb '12||Malartic||1|
|Orlando Chiropractor and Affinity Health & Well... (Jan '12)||Feb '12||Washington Chiro||20|
|Benitec Biopharma and Medistem Technologies Suc... (Feb '12)||Feb '12||Tanya Doyle||1|
|Judicial Watch Files Two Amicus Curiae Briefs W... (Feb '12)||Feb '12||Excellent||2|
Find what you want!
Search Marketwire Forum Now